Collaborative Practice Agreements for Pharmacists Explained
Co-Founder and Chief Data Scientist
A collaborative practice agreement can let a licensed pharmacist take on defined patient-care responsibilities, but it is not a blanket right to prescribe or practice independently. The details depend on state law, the collaborating clinician, and the written agreement. For pharmacy students, new graduates, and practicing pharmacists, those differences can determine whether a role is realistic and worth pursuing.
This guide explains what agreements authorize, what qualifications and safeguards to check, and how to decide whether a particular opportunity offers meaningful clinical practice.
Key Things You Should Know
- A collaborative practice agreement authorizes specified pharmacist activities under applicable state law and a written arrangement with an eligible clinician; its permissions are not portable across states.
- A Pharm.D. alone does not qualify someone to practice under an agreement: pharmacist licensure is essential, and additional training or experience may be required.
- Evaluate the actual protocol, supervision and documentation workload, and compensation - not just the job title. The U.S. pharmacist median annual pay was $140,910 in May 2025, but that figure does not isolate collaborative-practice jobs.
What is a collaborative practice agreement for pharmacists?
A collaborative practice agreement, or CPA, is a written arrangement under which a pharmacist and an eligible prescriber or other authorized clinician define patient-care activities the pharmacist may perform. State law controls who may participate, which activities may be delegated or authorized, and whether an agreement must be filed with or approved by a board or other authority.
A CPA usually identifies the patients or conditions covered and sets protocols for decisions, documentation, referrals, and communication. It does not replace the pharmacist's license or permit care outside its terms. A pharmacist who completed Doctor of Pharmacy study online must meet the same applicable licensure and state practice requirements as other pharmacists; the degree's delivery format does not create CPA authority.
How do collaborative practice agreements expand pharmacist responsibilities?
A CPA can move a pharmacist from identifying and recommending a medication change to carrying out a change within an authorized protocol. The distinction matters: authority comes from the combination of state law and the agreement, not from the pharmacist's clinical judgment alone.
The comparison below separates activities a pharmacist may ordinarily perform from those that may require a CPA. Baseline authority and exceptions still vary by state.
| Practice situation | Pharmacist's possible role | Authority to check |
| Medication review | Identify a problem and recommend a change to the prescriber | Pharmacist practice law and workplace policy |
| Protocol-based medication management | Initiate, adjust, or discontinue a covered medication when permitted | State law and the CPA's patient, drug, and condition limits |
| Monitoring and follow-up | Order or interpret specified tests and act on results when permitted | State testing rules, the protocol, and referral thresholds |
A CPA is one route to expanded practice, not the only one: some states grant particular pharmacist authorities directly through separate laws. Conversely, pharmacy degree options with shorter study periods do not substitute for the education and licensure required to act as a pharmacist under a CPA.
Which states allow pharmacist collaborative practice agreements?
All 50 states and Washington, D.C., have some mechanism for pharmacist collaborative practice. That broad answer does not mean the same agreement or service is legal everywhere. States differ on eligible collaborators, covered settings and patients, permitted drug or testing decisions, pharmacist qualifications, and approval or reporting requirements. State rules can also change.
Check the state where the patient receives care and the pharmacist is practicing, rather than assuming the pharmacy school's location controls. This is especially important for someone considering online pharmacy programs for science-background students: admission to a program, permission to complete rotations in a state, pharmacist licensure, and later CPA authority are separate questions.
The starting requirement is an active pharmacist license in the relevant jurisdiction. A professional Pharm.D. is an educational pathway toward pharmacist licensure, not a license itself. States or agreements may also require specified clinical experience, continuing education, certification, training in the covered service, or approval by a board or collaborating clinician. Employers may set stricter requirements than the law.
For a prospective student, pharmacy school acceptance criteria answer an earlier question than CPA eligibility. Before choosing a program for a clinical career goal, confirm its current Accreditation Council for Pharmacy Education professional-program status and investigate licensure requirements in the state where you intend to work. Accreditation of a program, graduation, and passing a licensing examination do not individually issue a pharmacist license.
Depending on state law and the protocol, services may include managing medications for a defined condition, adjusting doses, monitoring laboratory results, providing follow-up, or arranging referrals. Common clinical applications include chronic-disease medication management and care after a hospital discharge. A service is permissible only when the pharmacist, patient, condition, and proposed action all fall within the applicable authority.
Do not assume that permission to administer immunizations, furnish certain medications, or perform a test comes from a CPA; a state may authorize those activities under separate rules. Likewise, an agreement covering one disease or drug class does not automatically cover another. Students exploring pharmacy programs before all requirements are complete may observe or train under applicable supervision, but a CPA does not give an unlicensed student the authority of a licensed pharmacist.
The legally required contents vary by state, so use the applicable board's rules and any required form as the starting point. A workable agreement also needs enough operational detail that both clinicians know when the pharmacist may act and when care must return to the prescriber.
Before signing, check that the written agreement resolves these practical points:
- Who may participate, which patients and locations are covered, and when the agreement begins and ends.
- Which conditions, medications, tests, and specific decisions the pharmacist may manage.
- What clinical criteria, safety limits, and urgent referral triggers apply.
- How actions are recorded, how quickly the collaborator is notified, and how records are shared.
- Who reviews the protocol, handles coverage or absences, and updates or terminates the agreement.
If you are still working to evaluate credits for pharmacy prerequisites, this is a later-career checklist, not an admissions requirement. Keep the distinction clear: a school decides how prior coursework applies, while state law and the participating clinicians govern the CPA.
Pharm.D. education develops clinical reasoning, medication management, and patient-care skills. Introductory and advanced pharmacy practice experiences provide supervised practice, but completing them does not itself authorize independent CPA activities. After licensure, pharmacists may develop role-specific competence through employer onboarding, protocol training, continuing education, supervised practice, or postgraduate training.
A postgraduate year one (PGY1) residency builds broad practice experience; a PGY2 residency develops a more focused area. Neither is universally required for CPAs. A fellowship generally serves a different training purpose, and specialty board certification is a separate credential - not state licensure. Whether any of these is required for a particular role depends on the state, employer, and agreement.
When comparing online doctorate program length, do not treat a shorter academic timeline as proof of CPA readiness. Ask instead what supervised patient-care experience and postlicensure training the specific role requires.
CPAs can make pharmacist positions more clinically involved in ambulatory care, health systems, community-based services, and other team settings. Their career value depends on whether the employer has patients, collaborating clinicians, documentation systems, and protected time to make the protocol usable. A position advertised as "collaborative" may offer little additional decision-making if the agreement is narrow or never implemented.
The Bureau of Labor Statistics reports pharmacist median annual pay of $140,910 in May 2025 and projects 5% growth from 2025-2035, with about 12,500 openings per year. These figures cover pharmacists broadly; they do not establish a CPA salary premium or predict openings in a particular clinical setting.
Accelerated pharmacist education may change how soon a student finishes school, but it does not remove licensure requirements or guarantee a collaborative-practice position. Weigh any faster route against its cost, clinical experiences, and the qualifications employers seek for the role you want.
Verify the rules before negotiating responsibilities or accepting a job. The state board of pharmacy and current statutes and regulations are the primary starting points; also check any relevant medical or other professional board rules when the collaborator's authority is at issue.
Use this sequence to turn a general description of CPA authority into an answer for a specific role:
- Identify the state of practice, proposed service, patient population, and collaborating clinician.
- Read the current pharmacy practice statute, regulations, and board CPA guidance for that jurisdiction.
- Confirm pharmacist training, signatures, filing or approval, renewal, and recordkeeping requirements.
- Compare the proposed protocol with those rules and obtain clarification from the board or qualified legal counsel where the authority is unclear.
If you are planning affordable pharmacy studies with a focused timeline, do this jurisdiction check early. It can reveal whether your intended career path requires experience or training beyond the degree and license, rather than leaving that discovery until after graduation.
How should pharmacists evaluate collaborative practice opportunities?
Choose an opportunity based on its usable scope and support, not the presence of "CPA" in a job posting. Ask to review the proposed agreement before committing, and distinguish what the law permits from what the employer has actually arranged.
These questions expose the trade-offs that matter most:
- Which decisions can I make, for which patients, and what requires prescriber approval or referral?
- Is an eligible collaborator already committed, and who maintains the agreement if that person leaves?
- Will I have scheduled patient-care time, access to records and testing, and a reliable way to communicate decisions?
- What training, documentation, liability coverage, and performance expectations apply - and who pays for them?
- Does compensation reflect the added work, and what happens if the CPA is delayed or ends?
A narrow but well-supported protocol may be more valuable than broad authority without patients, time, or a collaborator. For a prospective student comparing online pharmacy school cost options, keep this career goal in view without assuming that paying more - or earning the degree faster - will secure a CPA role. Confirm educational costs and licensure eligibility separately from a future employer's practice arrangement.
Other Things You Should Know About PharmD
Possibly. State rules and workplace policies govern whether a pharmacist may participate in multiple agreements. Each must clearly define its collaborators, patients, and permitted activities.
It may, but telehealth does not erase state licensure, prescribing, patient-location, or documentation rules. Verify every jurisdiction involved before providing the service.
Do not assume so. Agreements identify particular participants and often specify a setting or patient population. Review the terms and state rules before using an existing agreement in a new position.
No. Legal authority to provide care and eligibility for reimbursement are separate. Check payer contracts, billing rules, and the employer's payment process before counting on service revenue.
- 318:16-a Standards for Collaborative Pharmacy Practice. | nh.gov https://gc.nh.gov/rsa/html/XXX/318/318-16-a.htm
- Pharmacy Collaborative Practice Certification | Florida Board of Pharmacy https://floridaspharmacy.gov/pharmacy-collaborative-practice-certification/
- Pharmacists' Patient Care Process: A State "Scope of Practice" Perspective - PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC7592868/
- States Can Empower Pharmacists to Prevent and Treat Infectious Diseases | ncsl.org https://www.ncsl.org/health/states-can-empower-pharmacists-to-prevent-and-treat-infectious-diseases
- Collaborative practice now allowed in all 50 states | pharmacist.com https://www.pharmacist.com/DesktopModules/EasyDNNNews/DocumentDownload.ashx
- Building Collaborative Practice Agreements for Clinical Pharmacy Teams 2026 | American College of Clinical Pharmacy https://careers.accp.com/career-resources/employer-4/building-collaborative-practice-agreements-for-clinical-pharmacy-teams-2026-27
- Collaborative Practice Agreements: Resources and More | NASPA https://naspa.us/resource/cpa/
